Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Men with hair loss experience lower quality of life, worsened by factors like age, severity, and treatment history.

Hair pain is more common in women with hair loss, but it's not linked to the cause or severity of hair loss.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

A woman's hair grew back after stopping acitretin for psoriasis and getting steroid treatment, and low vitamin D might be linked to alopecia severity.

The described COVID-19 treatments seemed effective in influencing the disease's course, duration, and severity.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

Female pattern hair loss severity is linked to physical signs of high androgens, not blood hormone levels.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Women with high androgen levels may have more severe COVID-19 symptoms.

Women with PCOS and higher BMI, especially those with morbid obesity, are at greater risk for depression.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

Combination therapy effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

Alopecia areata treatment varies, with no optimal method established yet.

Testosterone may influence COVID-19 severity and outcomes.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

Alopecia areata severity and symptoms vary by race and ethnicity.

Mineral levels in hair don't significantly affect the severity of atopic dermatitis in children.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Parental uveitis increases offspring's risk and severity of autoimmune eye disease.

Dermoscopy can help assess the severity of chronic radiation-induced skin damage in head and neck cancer patients.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

A new classification and scoring system is needed for alopecia areata to better assess severity.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Removing certain brain receptors in mice worsens seizure severity and response to treatment during hormone withdrawal.

Computer-aided imaging system helps measure balding area in female pattern hair loss.

Hereditary factors affect acne duration, not severity, and late-onset acne in females has different causes.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.